S. 4333 · 117th Congress
CLEAR Act
- Stage
- In committee
- Sponsor
- Tina Smith
- Introduced
- 2022-05-26
- Latest action
- 2022-05-26 · Introduced in Senate
Summary
Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act
This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.